The Dietary Approaches to Stop Hypertension (DASH) Eating Pattern in Special Populations

被引:46
作者
Tyson, Crystal C. [1 ,2 ,3 ]
Nwankwo, Chinazo [2 ,3 ]
Lin, Pao-Hwa [1 ,2 ]
Svetkey, Laura P. [1 ,2 ,3 ]
机构
[1] Duke Univ, Med Ctr, Dept Med, Div Nephrol, Durham, NC 27710 USA
[2] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Duke Hypertens Ctr, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
Hypertension; Prehypertention; Stage I hypertension; Blood pressure; BP; Diet; Nutrition therapy; Lifestyle interventions; Medication therapy; Combination therapy; Chronic kidney disease; CKD; Diabetes mellitus; DM; Cardiovascular disease; CVD; Renin-angiotensin-aldosterone system inhibitors; RAAS inhibitors; CONGESTIVE-HEART-FAILURE; JOINT NATIONAL COMMITTEE; BLOOD-PRESSURE; PROTEIN RESTRICTION; LIVER-DISEASE; WEIGHT-LOSS; MANAGEMENT; NUTRITION; ASSOCIATION; GUIDELINES;
D O I
10.1007/s11906-012-0296-1
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The Dietary Approaches to Stop Hypertension (DASH) trial showed that a diet rich in fruits, vegetables, low-fat dairy products with reduced total and saturated fat, cholesterol, and sugar-sweetened products effectively lowers blood pressure in individuals with prehypertension and stage I hypertension. Limited evidence is available on the safety and efficacy of the DASH eating pattern in special patient populations that were excluded from the trial. Caution should be exercised before initiating the DASH diet in patients with chronic kidney disease, chronic liver disease, and those who are prescribed renin-angiotensin-aldosterone system antagonist, but these conditions are not strict contraindications to DASH. Modifications to the DASH diet may be necessary to facilitate its use in patients with chronic heart failure, uncontrolled diabetes mellitus type II, lactose intolerance, and celiac disease. In general, the DASH diet can be adopted by most patient populations and initiated simultaneously with medication therapy and other lifestyle interventions.
引用
收藏
页码:388 / 396
页数:9
相关论文
共 65 条
[1]   Predictors of the development of hyperkalemia in patients using angiotensin-converting enzyme inhibitors [J].
Ahuja, TS ;
Freeman, D ;
Mahnken, JD ;
Agraharkar, M ;
Siddiqui, M ;
Memon, A .
AMERICAN JOURNAL OF NEPHROLOGY, 2000, 20 (04) :268-272
[2]   Effects of the dietary approaches to stop hypertension (DASH) diet on the pressure-natriuresis relationship [J].
Akita, S ;
Sacks, FM ;
Svetkey, LP ;
Conlin, PR ;
Kimura, G .
HYPERTENSION, 2003, 42 (01) :8-13
[4]  
[Anonymous], 2012, DIABETES CARE, V35, pS11, DOI [10.2337/dc35-S011, 10.2337/dc12-s004]
[5]  
[Anonymous], 2004, Am J Kidney Dis, V43, pS1, DOI DOI 10.1053/J.AJKD.2004.03.003
[6]  
Appel LJ, 2003, JAMA-J AM MED ASSOC, V289, P2083, DOI 10.1001/jama.289.16.2083
[7]   A clinical trial of the effects of dietary patterns on blood pressure [J].
Appel, LJ ;
Moore, TJ ;
Obarzanek, E ;
Vollmer, WM ;
Svetkey, LP ;
Sacks, FM ;
Bray, GA ;
Vogt, TM ;
Cutler, JA ;
Windhauser, MM ;
Lin, PH ;
Karanja, N .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (16) :1117-1124
[8]   Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids - Results of the OmniHeart randomized trial [J].
Appel, LJ ;
Sacks, FM ;
Carey, VJ ;
Obarzanek, E ;
Swain, JF ;
Miller, ER ;
Conlin, PR ;
Erlinger, TP ;
Rosner, BA ;
Laranjo, NM ;
Charleston, J ;
McCarron, P ;
Bishop, LM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (19) :2455-2464
[9]   Parenteral iron use in the management of anemia in end-stage renal disease patients [J].
Bailie, GR ;
Johnson, CA ;
Mason, NA .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (01) :1-12
[10]   Nutritional deficiencies in Celiac disease [J].
Barton, Susan H. ;
Kelly, Darlene G. ;
Murray, Joseph A. .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2007, 36 (01) :93-+